https://www.outsourcing-pharma.com en ℗ & © William Reed Ltd Breaking News on Outsourcing Pharma https://megaphone.imgix.net/podcasts/168872aa-cdbc-11ea-aad2-275978d65a2d/image/9e1c3a3ce80fe542acd20412ae22b214.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress https://www.outsourcing-pharma.com no episodic William Reed Ltd Breaking News on Outsourcing Pharma Breaking News on Outsourcing Pharma

]]> William Reed Ltd podcasts@wrbm.com Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast. Sun, 19 Oct 2014 23:00:00 -0000 full William Reed Ltd Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast. 193 Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth the cost. Tue, 26 Nov 2013 00:00:00 -0000 full William Reed Ltd Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth the cost. 150 Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit. Tue, 22 Oct 2013 23:00:00 -0000 full William Reed Ltd Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit. 291 In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, according to AlpVision. Mon, 06 May 2013 23:00:00 -0000 full William Reed Ltd In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, according to AlpVision. 257 Excipient firms that skip lot testing or use alternative analysis methods should justify their decisions according to a new COA guide issued by IPEC Americas.  Thu, 21 Feb 2013 00:00:00 -0000 full William Reed Ltd Excipient firms that skip lot testing or use alternative analysis methods should justify their decisions according to a new COA guide issued by IPEC Americas.  438 Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances from the FDA and the EMA. Mon, 12 Nov 2012 00:00:00 -0000 full William Reed Ltd Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances from the FDA and the EMA. 274 The positive impact drug industry demand for quality is having on the fine chemicals sector was evident at industry trade show CPhI last month according to expert Jan Ramakers.  Wed, 31 Oct 2012 00:00:00 -0000 full William Reed Ltd The positive impact drug industry demand for quality is having on the fine chemicals sector was evident at industry trade show CPhI last month according to expert Jan Ramakers.  311 CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition. Wed, 24 Oct 2012 23:00:00 -0000 full William Reed Ltd CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition. 226 Catalent says making its technology available to industry will not affect its competitive edge. Sun, 21 Oct 2012 23:00:00 -0000 full William Reed Ltd Catalent says making its technology available to industry will not affect its competitive edge. 304 Capsugel has expanded its Licaps liquid fill capsule line with a new facility in the US. Tue, 16 Oct 2012 23:00:00 -0000 full William Reed Ltd Capsugel has expanded its Licaps liquid fill capsule line with a new facility in the US. 294 Bend Research is “actively” hunting new partnerships similar to its recent alliance with Dow. Tue, 16 Oct 2012 23:00:00 -0000 full William Reed Ltd Bend Research is “actively” hunting new partnerships similar to its recent alliance with Dow. 295 The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July will put Europe on an equal playing field, according to Clinipace’s Andrea Schiefer. Mon, 20 Aug 2012 23:00:00 -0000 full William Reed Ltd The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July will put Europe on an equal playing field, according to Clinipace’s Andrea Schiefer. 317 Sartorius Stedim says its new range of sterilising-grade filters can allow steam cleaning in dry conditions and minimises protein binding. Mon, 25 Jun 2012 23:00:00 -0000 full William Reed Ltd Sartorius Stedim says its new range of sterilising-grade filters can allow steam cleaning in dry conditions and minimises protein binding. 316 Submitting a REMS (Risk Evaluation and Mitigation Strategies) proposal for risky drug developments could earn companies brownie points, according to Quintiles’ Ed Tabor. Tue, 12 Jun 2012 23:00:00 -0000 full William Reed Ltd Submitting a REMS (Risk Evaluation and Mitigation Strategies) proposal for risky drug developments could earn companies brownie points, according to Quintiles’ Ed Tabor. 311 Negotiating funding for drugs with local health authorities prior to commercialisation is the key to success for biopharmas working in the changing European market, says Quintiles. Wed, 06 Jun 2012 23:00:00 -0000 full William Reed Ltd Negotiating funding for drugs with local health authorities prior to commercialisation is the key to success for biopharmas working in the changing European market, says Quintiles. 343 A bigger initial pay-out for REMS means long-term profitability for drugsmakers, says Quintiles Ed Tabor. Tue, 05 Jun 2012 23:00:00 -0000 full William Reed Ltd A bigger initial pay-out for REMS means long-term profitability for drugsmakers, says Quintiles Ed Tabor. 313 The use of home visits in clinical trials could raise the chances of regulatory approval, according to ResearchNurses.co. Wed, 30 May 2012 23:00:00 -0000 full William Reed Ltd The use of home visits in clinical trials could raise the chances of regulatory approval, according to ResearchNurses.co. 298 Including home visits in clinical trial designs could be the key to patient retention, according to ResearchNurses.co. Tue, 29 May 2012 23:00:00 -0000 full William Reed Ltd Including home visits in clinical trial designs could be the key to patient retention, according to ResearchNurses.co. 369 ‘CROs: look at the entire portfolio, not just the individual project, when planning clinical studies,’ says DIA’s adaptive design scientific working group. Mon, 21 May 2012 23:00:00 -0000 full William Reed Ltd ‘CROs: look at the entire portfolio, not just the individual project, when planning clinical studies,’ says DIA’s adaptive design scientific working group. 280 Reduce changeover time on oral solid dose machinery by cleaning equipment offline, Fette Compacting urged drugsmakers at this year’s Interphex. Wed, 09 May 2012 23:00:00 -0000 full William Reed Ltd Reduce changeover time on oral solid dose machinery by cleaning equipment offline, Fette Compacting urged drugsmakers at this year’s Interphex. 230 Advancements in single-use equipment are crucial to the development of the biotechnology industry, according to experts at this year’s Interphex. Sun, 06 May 2012 23:00:00 -0000 full William Reed Ltd Advancements in single-use equipment are crucial to the development of the biotechnology industry, according to experts at this year’s Interphex. 322 SGS has added formulation development to its service offering through the expansion of its laboratory in Illinois. Sun, 06 May 2012 23:00:00 -0000 full William Reed Ltd SGS has added formulation development to its service offering through the expansion of its laboratory in Illinois. 201 The European CMO industry could be blocked by over complex layers of regulation, says Frost & Sullivan analyst Aiswariya Chidambaram. Tue, 24 Apr 2012 23:00:00 -0000 full William Reed Ltd The European CMO industry could be blocked by over complex layers of regulation, says Frost & Sullivan analyst Aiswariya Chidambaram. 358 Designing trials around patients’ habits is the key to success in patient compliance, according to online recruitment specialist Rebar Interactive. Sun, 15 Apr 2012 23:00:00 -0000 full William Reed Ltd Designing trials around patients’ habits is the key to success in patient compliance, according to online recruitment specialist Rebar Interactive. 316 Those seeking leadership positions in the pharmaceutical world should take to social networking sites to get noticed, recruitment specialists say. Mon, 09 Apr 2012 23:00:00 -0000 full William Reed Ltd Those seeking leadership positions in the pharmaceutical world should take to social networking sites to get noticed, recruitment specialists say. 321 Regulatory reform was the name of the game at this year’s DIA Euromeeting in Denmark. Wed, 04 Apr 2012 23:00:00 -0000 full William Reed Ltd Regulatory reform was the name of the game at this year’s DIA Euromeeting in Denmark. 208 Catalent wants to build on its European expansions by replicating the end-to-end drug development services model in emerging markets.  Tue, 03 Apr 2012 23:00:00 -0000 full William Reed Ltd Catalent wants to build on its European expansions by replicating the end-to-end drug development services model in emerging markets.  299 Planning supply chains early is an important part of maintaining margins but is often overlooked by Pharmas too focused on developing the next product in an era of patent expiry says industry consultant. Sun, 25 Mar 2012 23:00:00 -0000 full William Reed Ltd Planning supply chains early is an important part of maintaining margins but is often overlooked by Pharmas too focused on developing the next product in an era of patent expiry says industry consultant. 342 Aptar Pharma says its new eDevices can help companies gain quicker regulatory approval for their nasal drug products without having to re-do clinical trials. Tue, 21 Feb 2012 00:00:00 -0000 full William Reed Ltd Aptar Pharma says its new eDevices can help companies gain quicker regulatory approval for their nasal drug products without having to re-do clinical trials. 334 Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics. Wed, 25 Jan 2012 00:00:00 -0000 full William Reed Ltd Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics. 359 Excipient makers could save up to 200 man hours with a new industry-driven, third-party audit certification scheme set to launch next week. Tue, 17 Jan 2012 00:00:00 -0000 full William Reed Ltd Excipient makers could save up to 200 man hours with a new industry-driven, third-party audit certification scheme set to launch next week. 293 Sponsor and CRO perceptions of the quality of outsourced service provision differ markedly according to a study by consulting and survey research organisation, the Avoca Group. Thu, 08 Dec 2011 00:00:00 -0000 full William Reed Ltd Sponsor and CRO perceptions of the quality of outsourced service provision differ markedly according to a study by consulting and survey research organisation, the Avoca Group. 389 Taste masking plays a vital role in treatment compliance according to Cargill, which has launched a new flavour technology that it claims can make drugs more pleasant to take and help manufacturers save money. Wed, 30 Nov 2011 00:00:00 -0000 full William Reed Ltd Taste masking plays a vital role in treatment compliance according to Cargill, which has launched a new flavour technology that it claims can make drugs more pleasant to take and help manufacturers save money. 210 High potency APIs are becoming a key focus of the pharmaceutical business, with drug makers from all areas racing to establish a foothold in the market. Tue, 29 Nov 2011 00:00:00 -0000 full William Reed Ltd High potency APIs are becoming a key focus of the pharmaceutical business, with drug makers from all areas racing to establish a foothold in the market. 206 Contract services providers which embed service personnel in pharma companies are becoming more prominent in the industry. Mon, 21 Nov 2011 00:00:00 -0000 full William Reed Ltd Contract services providers which embed service personnel in pharma companies are becoming more prominent in the industry. 271 Endeavour Specialty Chemicals has launched a novel range of pyridinyl thioureas designed to cater for growing pharmaceutical industry interest in the development of prion disease treatments. Wed, 16 Nov 2011 00:00:00 -0000 full William Reed Ltd Endeavour Specialty Chemicals has launched a novel range of pyridinyl thioureas designed to cater for growing pharmaceutical industry interest in the development of prion disease treatments. 227 Almac says growing demand for non-GMP manufacturing work rather than competition was the key driver for expansion of its product development services business. Tue, 15 Nov 2011 00:00:00 -0000 full William Reed Ltd Almac says growing demand for non-GMP manufacturing work rather than competition was the key driver for expansion of its product development services business. 143 Asking the right questions is key to giving pharmaceutical industry contract managers the information they need to select the best CRO partners according to the team behind a new performance assessment project. Wed, 09 Nov 2011 00:00:00 -0000 full William Reed Ltd Asking the right questions is key to giving pharmaceutical industry contract managers the information they need to select the best CRO partners according to the team behind a new performance assessment project. 354 BASF says solubility and bioavailability will be key focus for its pharmaceutical excipient product development efforts in the next few years. Mon, 31 Oct 2011 00:00:00 -0000 full William Reed Ltd BASF says solubility and bioavailability will be key focus for its pharmaceutical excipient product development efforts in the next few years. 395 The human tissue supply industry is under pressure from CROs demanding more complex samples, according to equity analyst Vadim Alexandre. Mon, 26 Sep 2011 23:00:00 -0000 full William Reed Ltd The human tissue supply industry is under pressure from CROs demanding more complex samples, according to equity analyst Vadim Alexandre. 335 Pharma industry sponsors want more effective ways of measuring CRO performance according to the team behind a new project aiming to develop a validated set of analysis tools. Tue, 13 Sep 2011 23:00:00 -0000 full William Reed Ltd Pharma industry sponsors want more effective ways of measuring CRO performance according to the team behind a new project aiming to develop a validated set of analysis tools. 347 Companies outsourcing patient recruitment in emerging markets should have more people on the ground, according to Cutting Edge Information's Shaylyn Pike. Tue, 30 Aug 2011 23:00:00 -0000 full William Reed Ltd Companies outsourcing patient recruitment in emerging markets should have more people on the ground, according to Cutting Edge Information's Shaylyn Pike. 419 Companies looking to outsource patient recruitment need to think outside the box, says Cutting Edge Information’s director of research Eric Bolesh. Wed, 17 Aug 2011 23:00:00 -0000 full William Reed Ltd Companies looking to outsource patient recruitment need to think outside the box, says Cutting Edge Information’s director of research Eric Bolesh. 373 Outsourcing should play a vital role in any patient recruitment strategy, says Cutting Edge Information’s director of research Eric Bolesh. Mon, 15 Aug 2011 23:00:00 -0000 full William Reed Ltd Outsourcing should play a vital role in any patient recruitment strategy, says Cutting Edge Information’s director of research Eric Bolesh. 383 An evidence-based approach to planning during protocol development is key to successful patient recruitment according to Joseph Kim, director of clinical operations at Shire Pharmaceuticals. Sun, 31 Jul 2011 23:00:00 -0000 full William Reed Ltd An evidence-based approach to planning during protocol development is key to successful patient recruitment according to Joseph Kim, director of clinical operations at Shire Pharmaceuticals. 308 INC Research CEO James Ogle tells Outsourcing-pharma.com that the acquisition of fellow CRO Kendle was about building a presence in emerging trial hotspots and pharmaceutical markets. Wed, 27 Jul 2011 23:00:00 -0000 full William Reed Ltd INC Research CEO James Ogle tells Outsourcing-pharma.com that the acquisition of fellow CRO Kendle was about building a presence in emerging trial hotspots and pharmaceutical markets. 362 Firecrest Clinical has launched a mobile version of its site management and training platform, citing investigator demand for ‘trial in your hand solutions’ and sponsor demand for increased research efficiency. Mon, 20 Jun 2011 23:00:00 -0000 full William Reed Ltd Firecrest Clinical has launched a mobile version of its site management and training platform, citing investigator demand for ‘trial in your hand solutions’ and sponsor demand for increased research efficiency. 234 April saw the publication of the second draft of Excipact, a set of certification standards for third-party auditors of excipient manufacturers. Tue, 07 Jun 2011 23:00:00 -0000 full William Reed Ltd April saw the publication of the second draft of Excipact, a set of certification standards for third-party auditors of excipient manufacturers. 239 Parexel CEO Josef von Rickenbach predicts more Big Pharma strategic partnerships. Sun, 05 Jun 2011 23:00:00 -0000 full William Reed Ltd Parexel CEO Josef von Rickenbach predicts more Big Pharma strategic partnerships. 301 Pharma needs to learn from other sectors and abandon the multistage development paradigm in favour of a two-stage design and manufacturing model to cut attrition rates. Tue, 24 May 2011 23:00:00 -0000 full William Reed Ltd Pharma needs to learn from other sectors and abandon the multistage development paradigm in favour of a two-stage design and manufacturing model to cut attrition rates. 345 Continuous manufacturing offers significant advantages for drug production in terms of quality and efficiency, but more research and regulatory input is needed to help the pharmaceutical sector reap the benefits according to ISP. Mon, 18 Apr 2011 23:00:00 -0000 full William Reed Ltd Continuous manufacturing offers significant advantages for drug production in terms of quality and efficiency, but more research and regulatory input is needed to help the pharmaceutical sector reap the benefits according to ISP. 249 LB Bohle says healthy level of demand for processing technology demos at its recently opened service centre is an indication of processing tech market recovery. Wed, 06 Apr 2011 23:00:00 -0000 full William Reed Ltd LB Bohle says healthy level of demand for processing technology demos at its recently opened service centre is an indication of processing tech market recovery. 168 ATMI LifeSciences has introduced a new method of integrity testing for its range of single-use bioprocess vessels that, it claims, will take QA in the biomanufacturing sector to a new level. Sun, 03 Apr 2011 23:00:00 -0000 full William Reed Ltd ATMI LifeSciences has introduced a new method of integrity testing for its range of single-use bioprocess vessels that, it claims, will take QA in the biomanufacturing sector to a new level. 223 Next month the United Nations Conference on Trade and Development (UNCTAD) will organise a meeting to discuss ways of encouraging the production of pharmaceutical in Africa. Mon, 21 Mar 2011 00:00:00 -0000 full William Reed Ltd Next month the United Nations Conference on Trade and Development (UNCTAD) will organise a meeting to discuss ways of encouraging the production of pharmaceutical in Africa. 559 CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed. Mon, 14 Mar 2011 00:00:00 -0000 full William Reed Ltd CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed. 352 The mix of materials in confidential biopharm waste is a recycling challenge but also an opportunity to cut “ever increasing” landfill costs. Wed, 09 Mar 2011 00:00:00 -0000 full William Reed Ltd The mix of materials in confidential biopharm waste is a recycling challenge but also an opportunity to cut “ever increasing” landfill costs. 204 Contract packagers will lose deals if they fail to adapt to biopharm outsourcing “more and more” serialisation work, according to CEO of Covectra. Tue, 01 Mar 2011 00:00:00 -0000 full William Reed Ltd Contract packagers will lose deals if they fail to adapt to biopharm outsourcing “more and more” serialisation work, according to CEO of Covectra. 307 Clariant International has set up a unit to help the pharma sector overcome regulatory hurdles involved with developing colour packaging Thu, 24 Feb 2011 00:00:00 -0000 full William Reed Ltd Clariant International has set up a unit to help the pharma sector overcome regulatory hurdles involved with developing colour packaging 297 Big pharma has taken a less heavy handed approach to relationships as cutbacks have made outsourcing key, according to Stephen Munk, CEO of Ash Stevens. Thu, 03 Feb 2011 00:00:00 -0000 full William Reed Ltd Big pharma has taken a less heavy handed approach to relationships as cutbacks have made outsourcing key, according to Stephen Munk, CEO of Ash Stevens. 214 Solvent selection and solid loading are critical to optimising the spray drying process and unlocking its solubility-enhancing properties for drug production according to a new report by ISP Pharmaceuticals. Mon, 17 Jan 2011 00:00:00 -0000 full William Reed Ltd Solvent selection and solid loading are critical to optimising the spray drying process and unlocking its solubility-enhancing properties for drug production according to a new report by ISP Pharmaceuticals. 310 Kerri Weingard, research director for Accumed, says the growing numbers of patients enrolling in multiple clinical trials are threatening the integrity of the clinical development process. Tue, 30 Nov 2010 00:00:00 -0000 full William Reed Ltd Kerri Weingard, research director for Accumed, says the growing numbers of patients enrolling in multiple clinical trials are threatening the integrity of the clinical development process. 454 Almac invests $4m in biocatalysis R&D, describing such technologies as the way forward for the cost efficient production of highly chiral APIs and intermediates. Tue, 12 Oct 2010 23:00:00 -0000 full William Reed Ltd Almac invests $4m in biocatalysis R&D, describing such technologies as the way forward for the cost efficient production of highly chiral APIs and intermediates. 149 Recipharm says changes to Big Pharma and drug industry globalisation make having a worldwide manufacturing reach a virtual necessity for CDMOs. Mon, 11 Oct 2010 23:00:00 -0000 full William Reed Ltd Recipharm says changes to Big Pharma and drug industry globalisation make having a worldwide manufacturing reach a virtual necessity for CDMOs. 264 Mark Weinstein, CEO of Bioclinica, has hit back at a public letter from Nicusa Capital CEO, Paul Johnson, claiming that the company's corporate strategy is 'flawed' and demanding the resignation of three top executives. Wed, 06 Oct 2010 23:00:00 -0000 full William Reed Ltd Mark Weinstein, CEO of Bioclinica, has hit back at a public letter from Nicusa Capital CEO, Paul Johnson, claiming that the company's corporate strategy is 'flawed' and demanding the resignation of three top executives. 359 Adoption of electronic submission by regulators around the world is good news for drugmakers’ efforts to access emerging markets says industry expert Kate Wilber. Sun, 03 Oct 2010 23:00:00 -0000 full William Reed Ltd Adoption of electronic submission by regulators around the world is good news for drugmakers’ efforts to access emerging markets says industry expert Kate Wilber. 361 The US FDA’s risk evaluation mitigation strategy (REMS) can be a challenge for pharmaceutical companies unfamiliar with the process according to PPD’s executive director of risk management Frank Gallo. Tue, 21 Sep 2010 23:00:00 -0000 full William Reed Ltd The US FDA’s risk evaluation mitigation strategy (REMS) can be a challenge for pharmaceutical companies unfamiliar with the process according to PPD’s executive director of risk management Frank Gallo. 298 Addressing the drug industry's need to demonstrate value to stakeholders presents a significant opportunity for service providers, according to Jim Featherstone, VP of Quintiles' commercial arm. Wed, 15 Sep 2010 23:00:00 -0000 full William Reed Ltd Addressing the drug industry's need to demonstrate value to stakeholders presents a significant opportunity for service providers, according to Jim Featherstone, VP of Quintiles' commercial arm. 274 Clinical data management is, and will continue to be a key concern for the pharmaceutical industry, according to Susan Bornstein, executive vice president of eClinical solutions, who discussed the issue with Outsourcing-pharma earlier this week. Tue, 14 Sep 2010 23:00:00 -0000 full William Reed Ltd Clinical data management is, and will continue to be a key concern for the pharmaceutical industry, according to Susan Bornstein, executive vice president of eClinical solutions, who discussed the issue with Outsourcing-pharma earlier this week. 228 Scientists say counterfeit drug and ingredient detection using NQR could benefit both manufacturers and pharmacies. Sun, 12 Sep 2010 23:00:00 -0000 full William Reed Ltd Scientists say counterfeit drug and ingredient detection using NQR could benefit both manufacturers and pharmacies. 206 Patient recruiters and national regulators must learn from each other to better understand outreach tactics and how they fit with a country’s ethics and laws. Mon, 06 Sep 2010 23:00:00 -0000 full William Reed Ltd Patient recruiters and national regulators must learn from each other to better understand outreach tactics and how they fit with a country’s ethics and laws. 262 Tracking “non-content” metadata is an important part of any pharmaceutical submission, yet many drugmakers fail to take an integrated approach to the task according to regulatory expert Kate Wilber. Tue, 31 Aug 2010 23:00:00 -0000 full William Reed Ltd Tracking “non-content” metadata is an important part of any pharmaceutical submission, yet many drugmakers fail to take an integrated approach to the task according to regulatory expert Kate Wilber. 315 Biomarkers are critical to discovery and can help pharmaceutical firms make development a more efficient and cost effective process accord to bioanalysis services provider KCAS. Sun, 29 Aug 2010 23:00:00 -0000 full William Reed Ltd Biomarkers are critical to discovery and can help pharmaceutical firms make development a more efficient and cost effective process accord to bioanalysis services provider KCAS. 279 Almac says an effective biomarker strategy boosts a drug candidates’ chance of success and can ultimately add value to a developer’s business by opening door to diagnostics. Wed, 25 Aug 2010 23:00:00 -0000 full William Reed Ltd Almac says an effective biomarker strategy boosts a drug candidates’ chance of success and can ultimately add value to a developer’s business by opening door to diagnostics. 280 The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian. Tue, 24 Aug 2010 23:00:00 -0000 full William Reed Ltd The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian. 484 Proposed changes to USP chapters 232 and 233 on trace impurities would increase drug industry use of automated analysis, creating “huge number” of potential new customers says Thermo Fisher Scientific. Mon, 23 Aug 2010 23:00:00 -0000 full William Reed Ltd Proposed changes to USP chapters 232 and 233 on trace impurities would increase drug industry use of automated analysis, creating “huge number” of potential new customers says Thermo Fisher Scientific. 289 In the first of a series of special in-pharmatechnologist podcasts Kate Wilber, Image Solutions’ (ISI) director of regulatory Services, Europe discusses the emerging trends in BPO and talks about how it can benefit drugmakers. Tue, 03 Aug 2010 23:00:00 -0000 full William Reed Ltd In the first of a series of special in-pharmatechnologist podcasts Kate Wilber, Image Solutions’ (ISI) director of regulatory Services, Europe discusses the emerging trends in BPO and talks about how it can benefit drugmakers. 424 eResearchTechnology (ERT) says self-rated IVR technology can help clinical trial sponsors meet “suicidality monitoring” requirements. Sun, 01 Aug 2010 23:00:00 -0000 full William Reed Ltd eResearchTechnology (ERT) says self-rated IVR technology can help clinical trial sponsors meet “suicidality monitoring” requirements. 241 Demand for drug discovery services is growing again according to Domainex, who predicted that we will see greater pharmaceutical industry reliance on specialist CROs going forward. Wed, 28 Jul 2010 23:00:00 -0000 full William Reed Ltd Demand for drug discovery services is growing again according to Domainex, who predicted that we will see greater pharmaceutical industry reliance on specialist CROs going forward. 295 CRO Quintiles says biomarkers give insight into cancer drug candidates’ efficacy earlier in the development process, reducing trial costs and duration. Mon, 26 Jul 2010 23:00:00 -0000 full William Reed Ltd CRO Quintiles says biomarkers give insight into cancer drug candidates’ efficacy earlier in the development process, reducing trial costs and duration. 411 Quintiles’ Jay Norman tells Outsourcing-pharma that data sharing and patient and payer concerns will drive drug industry competition and clinical development decisions accord to new research. Mon, 12 Jul 2010 23:00:00 -0000 full William Reed Ltd Quintiles’ Jay Norman tells Outsourcing-pharma that data sharing and patient and payer concerns will drive drug industry competition and clinical development decisions accord to new research. 342 The role of the pharma industry in supporting the COE anti-counterfeiting treaty, which aims to criminalise activities, “cannot be underestimated”, according to a directorate member. Tue, 15 Jun 2010 23:00:00 -0000 full William Reed Ltd The role of the pharma industry in supporting the COE anti-counterfeiting treaty, which aims to criminalise activities, “cannot be underestimated”, according to a directorate member. 300 Increased focus on post-market safety and value has resulted in CROs handling more Phase IV work, according to a PharmaNet EVP, and this trend may continue as regulators seek real world evidence. Wed, 02 Jun 2010 23:00:00 -0000 full William Reed Ltd Increased focus on post-market safety and value has resulted in CROs handling more Phase IV work, according to a PharmaNet EVP, and this trend may continue as regulators seek real world evidence. 326 Russia, the Ukraine and Belarus have emerged as destinations for clinical studies and now offer “enormous” potential according to US-based CRO ClinStar. Mon, 12 Apr 2010 23:00:00 -0000 full William Reed Ltd Russia, the Ukraine and Belarus have emerged as destinations for clinical studies and now offer “enormous” potential according to US-based CRO ClinStar. 286 Recipharm CEO Thomas Eldered reflects on RecipharmCobra Biologics (RCB) launch, telling Outsourcing-pharma that US is key market. Sun, 28 Mar 2010 23:00:00 -0000 full William Reed Ltd Recipharm CEO Thomas Eldered reflects on RecipharmCobra Biologics (RCB) launch, telling Outsourcing-pharma that US is key market. 250 Liquent and Take Solutions say their new partnership provides pharmaceutical firms with an efficient, cost effective outsourced solution for regulatory publication and submissions. Wed, 24 Mar 2010 00:00:00 -0000 full William Reed Ltd Liquent and Take Solutions say their new partnership provides pharmaceutical firms with an efficient, cost effective outsourced solution for regulatory publication and submissions. 273 CEO Steffen Mittwich updates in-PharmaTechnologist on Atacama Labs' pneumatic dry granulation (PDG) API processing tech, its deal with German CMO Excella and future development plans. Thu, 18 Mar 2010 00:00:00 -0000 full William Reed Ltd CEO Steffen Mittwich updates in-PharmaTechnologist on Atacama Labs' pneumatic dry granulation (PDG) API processing tech, its deal with German CMO Excella and future development plans. 268 INC Research is partnering with invivodata to add ePRO to its offering, selecting the eClinical firm over its competitors in part because it understands the “aggressive” approach the CRO takes. Tue, 16 Mar 2010 00:00:00 -0000 full William Reed Ltd INC Research is partnering with invivodata to add ePRO to its offering, selecting the eClinical firm over its competitors in part because it understands the “aggressive” approach the CRO takes. 240 E Research Technology (ERT) launches Centralised Cardiac Safety 2.0 (CCS 2.0) service for ECG data and says approach improves efficiency, cuts costs and helps sponsors reach database lock quicker than distributed model. Mon, 15 Mar 2010 00:00:00 -0000 full William Reed Ltd E Research Technology (ERT) launches Centralised Cardiac Safety 2.0 (CCS 2.0) service for ECG data and says approach improves efficiency, cuts costs and helps sponsors reach database lock quicker than distributed model. 241 Contract services giant Quintiles has continued its expansion in Africa with a new clinical research services office in Nairobi, Kenya. Thu, 11 Mar 2010 00:00:00 -0000 full William Reed Ltd Contract services giant Quintiles has continued its expansion in Africa with a new clinical research services office in Nairobi, Kenya. 304 An adaptive approach to both the design and operation of a clinical trial can boost efficiency, reduce timelines and cut costs says Health Decisions' CEO Michael Rosenberg. Wed, 10 Mar 2010 00:00:00 -0000 full William Reed Ltd An adaptive approach to both the design and operation of a clinical trial can boost efficiency, reduce timelines and cut costs says Health Decisions' CEO Michael Rosenberg. 188 Payne Security has acquired BP Secure Solutions, adding the UK firm's roster of adhesive security labelling technologies to its drug industry offering. Mon, 08 Mar 2010 00:00:00 -0000 full William Reed Ltd Payne Security has acquired BP Secure Solutions, adding the UK firm's roster of adhesive security labelling technologies to its drug industry offering. 353 SAFC Pharma is preparing for the shift towards cell culture-based vaccines, while still supplying and growing in the traditional sector, to ensure it can grow in coming years, according to a company director. Thu, 25 Feb 2010 00:00:00 -0000 full William Reed Ltd SAFC Pharma is preparing for the shift towards cell culture-based vaccines, while still supplying and growing in the traditional sector, to ensure it can grow in coming years, according to a company director. 246 There are signs that 2010 will be a better year for the fine and custom chemistry industry but companies at Informex remained cautious and are planning accordingly. Mon, 22 Feb 2010 00:00:00 -0000 full William Reed Ltd There are signs that 2010 will be a better year for the fine and custom chemistry industry but companies at Informex remained cautious and are planning accordingly. 117 The impact of the economic downturn is still being felt but SAFC remains "cautiously optimistic" about 2010, believing its close relationships with clients and investment in key emerging markets will generate business. Thu, 18 Feb 2010 00:00:00 -0000 full William Reed Ltd The impact of the economic downturn is still being felt but SAFC remains "cautiously optimistic" about 2010, believing its close relationships with clients and investment in key emerging markets will generate business. 278 The capabilities of the MDS Pharma Services' sites Ricerca is set to acquire "perfectly dovetail" with its existing capacity, according to a company vice president. Wed, 17 Feb 2010 00:00:00 -0000 full William Reed Ltd The capabilities of the MDS Pharma Services' sites Ricerca is set to acquire "perfectly dovetail" with its existing capacity, according to a company vice president. 256 Clinical trials are often biased against the recruitment of older people says the European Union's PREDICT group, which has launched a charter designed to protect such patients' right to take part. Tue, 16 Feb 2010 00:00:00 -0000 full William Reed Ltd Clinical trials are often biased against the recruitment of older people says the European Union's PREDICT group, which has launched a charter designed to protect such patients' right to take part. 349 Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar. Mon, 08 Feb 2010 00:00:00 -0000 full William Reed Ltd Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar. 311 Conducting trials in smaller patient populations when developing personalised medicines poses challenges, such as how to recruit patients fast enough, but these can be overcome using adaptive methods, according to a CEO. Thu, 14 Jan 2010 00:00:00 -0000 full William Reed Ltd Conducting trials in smaller patient populations when developing personalised medicines poses challenges, such as how to recruit patients fast enough, but these can be overcome using adaptive methods, according to a CEO. 175 UK contract services firm Quotient Bioresearch says its "Synthesis-to-clinic" service for 14 C labelled compounds can simplify early drug development. Tue, 24 Nov 2009 00:00:00 -0000 full William Reed Ltd UK contract services firm Quotient Bioresearch says its "Synthesis-to-clinic" service for 14 C labelled compounds can simplify early drug development. 310 AAPS 2009 has drawn to a close but over the three days numerous trends and debates emerged, including the strategies CROs are using in the downturn, and we take a look at these in our conference round up. Thu, 12 Nov 2009 00:00:00 -0000 full William Reed Ltd AAPS 2009 has drawn to a close but over the three days numerous trends and debates emerged, including the strategies CROs are using in the downturn, and we take a look at these in our conference round up. 165 Following the first full day of AAPS 2009 in Los Angeles, California, US we take a look at the major developments and talking points. Tue, 10 Nov 2009 00:00:00 -0000 full William Reed Ltd Following the first full day of AAPS 2009 in Los Angeles, California, US we take a look at the major developments and talking points. 127 As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success. Wed, 14 Oct 2009 23:00:00 -0000 full William Reed Ltd As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success. 146 We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies. Wed, 07 Oct 2009 23:00:00 -0000 full William Reed Ltd We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies. 125 Transcrip Partners’ “augmentation” solution for contract R&D “differs from the normal consultancy alternative by fielding ‘doers’ who can think strategically and ‘thinkers’ who are happy to get their hands dirty” according to senior partner Paul Branthwaite. Tue, 08 Sep 2009 23:00:00 -0000 full William Reed Ltd Transcrip Partners’ “augmentation” solution for contract R&D “differs from the normal consultancy alternative by fielding ‘doers’ who can think strategically and ‘thinkers’ who are happy to get their hands dirty” according to senior partner Paul Branthwaite. 266 US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production. Tue, 30 Jun 2009 23:00:00 -0000 full William Reed Ltd US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production. 393 At BIO 2009 Symyx was promoting its new CDMO offering, which it believes meets a “real need in the industry” and can save clients time and materials by leveraging its prior knowledge. Tue, 02 Jun 2009 23:00:00 -0000 full William Reed Ltd At BIO 2009 Symyx was promoting its new CDMO offering, which it believes meets a “real need in the industry” and can save clients time and materials by leveraging its prior knowledge. 144 UK CRO Quotient Bioresearch has bought a clinical research facility in Edinburgh, Scotland, which in conjunction with an existing unit in Nottingham, England will serve as a base for its new Quotient Clinical unit. Tue, 19 May 2009 23:00:00 -0000 full William Reed Ltd UK CRO Quotient Bioresearch has bought a clinical research facility in Edinburgh, Scotland, which in conjunction with an existing unit in Nottingham, England will serve as a base for its new Quotient Clinical unit. 289 UK software group Cisiv has unveiled a web-based EDC platform, Baseline Plus, which is specifically tailored to meet the demands of post market trials. Wed, 06 May 2009 23:00:00 -0000 full William Reed Ltd UK software group Cisiv has unveiled a web-based EDC platform, Baseline Plus, which is specifically tailored to meet the demands of post market trials. 322 Two recombinant human albumins made by Novozymes' biopharma division have become the first to comply with the USP-NF's recently revised excipient monograph. Sun, 03 May 2009 23:00:00 -0000 full William Reed Ltd Two recombinant human albumins made by Novozymes' biopharma division have become the first to comply with the USP-NF's recently revised excipient monograph. 319 Tom Beil, SAFC’s VP of Quality and Regulatory affairs, whose talk on fine chemicals supply was a highlight of last month's DCAT week, spoke with in-PharmaTechnologist about the benefits and risks of working with global suppliers. Mon, 06 Apr 2009 23:00:00 -0000 full William Reed Ltd Tom Beil, SAFC’s VP of Quality and Regulatory affairs, whose talk on fine chemicals supply was a highlight of last month's DCAT week, spoke with in-PharmaTechnologist about the benefits and risks of working with global suppliers. 290 Michael Schmitt, president of Alcan Global Pharmaceutical Packaging, believes a recovery in the global economy, the increasing demand for quality and the emergence of markets like India and Brazil will be key drivers for the packaging sector over the next few years. Mon, 23 Mar 2009 00:00:00 -0000 full William Reed Ltd Michael Schmitt, president of Alcan Global Pharmaceutical Packaging, believes a recovery in the global economy, the increasing demand for quality and the emergence of markets like India and Brazil will be key drivers for the packaging sector over the next few years. 257 With M&A activity dominating Big Pharma's agenda at the moment, the contract research market is having to evolve and adapt to the turbulent environmnet. Outsourcing-pharma asked Frost & Sullivan analyst Barath Shankar to offer his opinion on the state of the sector and to predict how it will develop. Thu, 05 Mar 2009 00:00:00 -0000 full William Reed Ltd With M&A activity dominating Big Pharma's agenda at the moment, the contract research market is having to evolve and adapt to the turbulent environmnet. Outsourcing-pharma asked Frost & Sullivan analyst Barath Shankar to offer his opinion on the state of the sector and to predict how it will develop. 308 This week in-PharmaTechnologist's Pharma Phacts podcast focuses on a nanotechnology method that could produce more effective barrier packaging using less material. Wed, 25 Feb 2009 00:00:00 -0000 full William Reed Ltd This week in-PharmaTechnologist's Pharma Phacts podcast focuses on a nanotechnology method that could produce more effective barrier packaging using less material. 126 New research suggests that deuteration, the replacement of hydrogen atoms with heavier forms, can alter an API's crystallisation properties and help drugmakers make better more effective drugs. Mon, 09 Feb 2009 00:00:00 -0000 full William Reed Ltd New research suggests that deuteration, the replacement of hydrogen atoms with heavier forms, can alter an API's crystallisation properties and help drugmakers make better more effective drugs. 115 Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman Matt Stober about the new plant. Wed, 21 Jan 2009 00:00:00 -0000 full William Reed Ltd Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman Matt Stober about the new plant. 230 Since its inauguration last year, IPEC China has been working to improve the quality of excipient manufacturing in the country. in-PharmaTechnologist spoke with organisation president Nevin Cheng about the steps the body has taken so far and what it will be doing in 2009, including its plans for a new SFDA approved Drug Master File (DMF) scheme. Mon, 12 Jan 2009 00:00:00 -0000 full William Reed Ltd Since its inauguration last year, IPEC China has been working to improve the quality of excipient manufacturing in the country. in-PharmaTechnologist spoke with organisation president Nevin Cheng about the steps the body has taken so far and what it will be doing in 2009, including its plans for a new SFDA approved Drug Master File (DMF) scheme. 270 The timely identification of contaminants in pharmaceutical manufacture can be critical to avoiding costly delays. While it is relatively straightforward to establish the composition of a contaminating particle, determining its origin in the manufacturing process can be much more problematic. in-PharmaTechnologist spoke with McCrone Associates' Heidi Ullberg at this year's AAPS in Atlanta about a light microscopy that can help drugmakers address this problem. Thu, 11 Dec 2008 00:00:00 -0000 full William Reed Ltd The timely identification of contaminants in pharmaceutical manufacture can be critical to avoiding costly delays. While it is relatively straightforward to establish the composition of a contaminating particle, determining its origin in the manufacturing process can be much more problematic. in-PharmaTechnologist spoke with McCrone Associates' Heidi Ullberg at this year's AAPS in Atlanta about a light microscopy that can help drugmakers address this problem. 258 Icon's recent $43.2m acquisition of New York-based Prevalere Life Sciences is the latest part of the firm's expansion in the US CRO market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical development, Brian O'Dwyer, and Prevalere CEO Mario Rocci from a busy AAPS conference in Atlanta. Mon, 08 Dec 2008 00:00:00 -0000 full William Reed Ltd Icon's recent $43.2m acquisition of New York-based Prevalere Life Sciences is the latest part of the firm's expansion in the US CRO market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical development, Brian O'Dwyer, and Prevalere CEO Mario Rocci from a busy AAPS conference in Atlanta. 264 American Association of Pharmaceutical Scientist's (AAPS) president Dr Karen Habucky sets out the programme for the group's forthcoming annual meeting and exposition, which is being held in Atlanta, US between November 16- 20. Mon, 10 Nov 2008 00:00:00 -0000 full William Reed Ltd American Association of Pharmaceutical Scientist's (AAPS) president Dr Karen Habucky sets out the programme for the group's forthcoming annual meeting and exposition, which is being held in Atlanta, US between November 16- 20. 347 All the breaking news across the pharmaceutical manufacturing and outsourcing sectors. Mon, 03 Nov 2008 00:00:00 -0000 full William Reed Ltd All the breaking news across the pharmaceutical manufacturing and outsourcing sectors. 140